Primary progressive multiple sclerosis: cerebrospinal fluid considerations

Mark S Freedman1

  • 1Department of Medicine (Neurology), University of Ottawa, Ottawa Hospital General Campus, 501 Smith Road, Box 601, Ottawa, Ontario K1H 8L6, Canada. mfreedman@ottawahospital.on.ca

Multiple Sclerosis (Houndmills, Basingstoke, England)
|June 29, 2004
PubMed

Insights

Diagnosing primary progressive multiple sclerosis (PPMS) can be challenging. Cerebrospinal fluid (CSF) analysis, when used correctly, is a valuable tool for confirming PPMS diagnoses and differentiating it from other neurological conditions.

Area of Science:

  • Neurology
  • Neuroimmunology
  • Neurodegeneration

Background:

  • Primary progressive multiple sclerosis (PPMS) diagnosis requires excluding other chronic neurodegenerative CNS diseases.
  • PPMS is characterized by less inflammation than other MS types, increasing diagnostic complexity.
  • Many conditions mimic PPMS, necessitating precise diagnostic criteria.

Purpose of the Study:

  • To explore the diagnostic utility of cerebrospinal fluid (CSF) in primary progressive multiple sclerosis (PPMS).
  • To outline the current state of CSF analysis for PPMS diagnosis.
  • To highlight CSF's role in differentiating PPMS from other central nervous system (CNS) disorders.

Main Methods:

  • Review of current diagnostic schemes for multiple sclerosis (MS).
  • Analysis of pathological and imaging studies related to PPMS.
  • Exploration of cerebrospinal fluid (CSF) biomarkers and analysis techniques.

Main Results:

  • New MS diagnostic criteria mandate typical MS abnormalities in CSF.
  • PPMS can exist even without typical MS CSF findings.
  • CSF analysis provides crucial insights into the disease process.

Conclusions:

  • Cerebrospinal fluid (CSF) analysis is essential for diagnosing primary progressive multiple sclerosis (PPMS).
  • Proper utilization of CSF analysis aids in clarifying PPMS diagnoses.
  • CSF findings help distinguish PPMS from other chronic neurodegenerative CNS diseases.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cerebrospinal Fluid01:21

Cerebrospinal Fluid

Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...